Quidel Corporation Total Liabilities
Quidel Corporation total liabilities. Based on the latest financial reports, Quidel Corporation (QDEL) has total liabilities worth $3.94 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Quidel Corporation's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Quidel Corporation (1985–2025)
Total liabilities of Quidel Corporation from 1985 to 2025. This chart illustrates how Quidel Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore Quidel Corporation long-term investment intensity to see how much of total assets are deployed in long-term investments.
Quidel Corporation Competitors by Total Liabilities
The table below lists competitors of Quidel Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ArcherMind Technology Nanjing Co Ltd
SHE:300598
|
China | CN¥1.26 Billion |
|
Droneshield Ltd
AU:DRO
|
Australia | AU$38.99 Million |
|
Southern Cross Electrical Engineering Ltd
AU:SXE
|
Australia | AU$281.07 Million |
|
Artis Real Estate Investment Trust
TO:AX-UN
|
Canada | CA$1.19 Billion |
|
Treasure ASA
OL:TRE
|
Norway | Nkr35.00K |
|
XiAn ChenXi Aviation Technology Corp Ltd
SHE:300581
|
China | CN¥237.16 Million |
|
Neuca S.A.
WAR:NEU
|
Poland | zł4.97 Billion |
|
Andersen Group Inc.
NYSE:ANDG
|
USA | $579.88 Million |
Liability Composition Analysis (1985–2025)
This chart breaks down Quidel Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Quidel Corporation asset portfolio.
Liquidity & Leverage Metrics
Quidel Corporation Total Liabilities Ratios Explained
Quidel Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Quidel Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Quidel Corporation (1985–2025)
The table below shows the annual total liabilities of Quidel Corporation from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.85 Billion | +11.91% |
| 2024-12-31 | $3.44 Billion | -3.32% |
| 2023-12-31 | $3.56 Billion | -9.28% |
| 2022-12-31 | $3.92 Billion | +682.67% |
| 2021-12-31 | $501.00 Million | -6.96% |
| 2020-12-31 | $538.46 Million | +53.39% |
| 2019-12-31 | $351.05 Million | -7.81% |
| 2018-12-31 | $380.79 Million | -46.23% |
| 2017-12-31 | $708.15 Million | +277.44% |
| 2016-12-31 | $187.62 Million | -0.11% |
| 2015-12-31 | $187.83 Million | -7.20% |
| 2014-12-31 | $202.40 Million | +324.27% |
| 2013-12-31 | $47.71 Million | +12.73% |
| 2012-12-31 | $42.32 Million | -54.74% |
| 2011-12-31 | $93.51 Million | -8.39% |
| 2010-12-31 | $102.07 Million | +155.85% |
| 2009-12-31 | $39.90 Million | +69.25% |
| 2008-12-31 | $23.57 Million | -9.81% |
| 2007-12-31 | $26.14 Million | +9.94% |
| 2006-12-31 | $23.77 Million | -10.65% |
| 2005-12-31 | $26.61 Million | +18.21% |
| 2004-12-31 | $22.51 Million | -18.07% |
| 2003-12-31 | $27.47 Million | +38.47% |
| 2002-12-31 | $19.84 Million | -9.77% |
| 2001-12-31 | $21.98 Million | -7.34% |
| 2000-12-31 | $23.73 Million | -2.37% |
| 1999-12-31 | $24.30 Million | +207.59% |
| 1998-12-31 | $7.90 Million | -27.52% |
| 1997-12-31 | $10.90 Million | +53.52% |
| 1996-12-31 | $7.10 Million | -6.58% |
| 1995-12-31 | $7.60 Million | -28.30% |
| 1994-12-31 | $10.60 Million | 0.00% |
| 1993-12-31 | $10.60 Million | +2.91% |
| 1992-12-31 | $10.30 Million | +7.29% |
| 1991-12-31 | $9.60 Million | -38.06% |
| 1990-12-31 | $15.50 Million | +142.19% |
| 1989-12-31 | $6.40 Million | +3.23% |
| 1988-12-31 | $6.20 Million | +63.16% |
| 1987-12-31 | $3.80 Million | -30.91% |
| 1986-12-31 | $5.50 Million | +243.75% |
| 1985-12-31 | $1.60 Million | -- |
About Quidel Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more